Chest pressure or pain lasting more than a few minutes, pain spreading to the arm, jaw, neck or back, sudden breathlessness, a cold sweat, fainting, or a leg that suddenly turns cold, pale and painful are emergency signs. Call 911 or your local emergency number now.
Most chest twinges and most leg aches have ordinary explanations. Muscle strain, reflux, anxiety, short sleep, heavy training and simple deconditioning are far more common than arterial narrowing, and none of them show up on a lipid panel.
Most chest and leg discomfort comes from everyday causes rather than a narrowed artery, and plaque itself usually produces nothing noticeable until it is well advanced. Research suggests that a substantial number of people with coronary artery disease go undetected, which is why scans performed for unrelated reasons are regarded as an untapped chance to spot calcified plaque 1.
Before thinking about arteries, it is worth working through the ordinary explanations.
When narrowing is the explanation, the pattern is usually predictable rather than random. Discomfort from the heart tends to come on with exertion or emotional stress, feels like pressure, tightness, squeezing or heaviness rather than a sharp point, and eases within a few minutes of stopping. It can spread to the jaw, neck, shoulder, arm or upper back, and it can arrive as breathlessness, nausea, unusual fatigue or sweating with little or no chest pain at all. That last pattern matters, because research suggests that clinical presentation in women can differ from the classic picture 2.
Narrowing in the legs follows its own pattern. The classic version is cramping, aching or heaviness in the calf, thigh or buttock that begins after a fairly consistent walking distance and settles within minutes of standing still. Other signs include cold feet, pale or shiny skin, hair loss over the lower leg, toenail changes and sores that are slow to heal. In people with diabetes, nerve damage can blunt the pain signal so the usual walking cramp never appears, and research suggests that diagnosis in this group is harder and relies on more than the standard bedside test 3.
No blood test can see a blockage, but four markers help a clinician judge how likely plaque is to be forming and progressing over time. They describe the environment inside your arteries, not the state of any single vessel.
| Marker | Why it is linked to this symptom | What a result can and cannot tell you |
|---|---|---|
| LDL cholesterol | LDL particles deposit cholesterol in the artery wall, which is the starting point of plaque | Can show how much atherogenic cholesterol is circulating; cannot show whether plaque already exists or where |
| Apolipoprotein B | Counts the number of plaque-forming particles rather than the cholesterol inside them | Can reveal a high particle burden hidden behind an acceptable LDL figure; cannot confirm narrowing or predict when symptoms start |
| Lipoprotein (a) | A largely inherited particle that standard lipid panels do not measure | Can identify an inherited contribution to risk, usually stable for life; cannot grade how blocked an artery is |
| C-reactive protein | A general measure of inflammation, which is part of how plaque forms and becomes unstable | Can add context to lipid results; cannot localise inflammation to an artery or distinguish it from infection or recent hard training |
Typical reporting conventions for these markers are shown below.
| Marker | Common unit | Typical reference framing |
|---|---|---|
| LDL cholesterol | mg/dL | Many labs regard values under 100 mg/dL as desirable in adults without known heart disease |
| Apolipoprotein B | mg/dL | Commonly reported against a desirable value in the region of 90 mg/dL, with lab-specific cut points |
| Lipoprotein (a) | nmol/L or mg/dL | Often flagged above roughly 75 nmol/L or roughly 30 mg/dL; the two units are not interchangeable |
| High-sensitivity CRP | mg/L | Under 1 mg/L is commonly reported as low, 1 to 3 as intermediate, above 3 as higher |
These are typical laboratory reference framings, not diagnostic cut-offs. Ranges vary by laboratory, by age and by sex, and the range printed on your own report is the one that applies to your sample.
Yes. LDL cholesterol can sit above the desirable range for decades while you feel completely well, because plaque grows inside the artery wall long before it narrows the channel enough to limit blood flow.
The mechanism is unglamorous. LDL particles cross into the artery wall, some are retained there, and the immune response to that retained cholesterol builds the fatty, fibrous deposit that becomes a plaque. Research suggests that LDL cholesterol acts as a causal agent in atherosclerosis rather than a passive marker alongside it 4. Research also suggests that cardiovascular risk continues to fall as LDL cholesterol goes lower, which is why clinical thinking has moved away from a single pass or fail line and towards a view of cumulative lifetime exposure 5.
Plenty of things other than artery health move this number. Saturated fat intake, rapid weight gain or weight loss, pregnancy, thyroid function, kidney and liver conditions, and the few weeks after an acute illness or surgery can all shift LDL cholesterol. The calculation method matters too, since many labs estimate LDL from other values and that estimate drifts when triglycerides are high.
In practice, a single raised reading is an observation rather than a conclusion. It may reflect genuine long-term exposure, or a temporary phase, and the useful next step is a repeat measurement in context alongside the rest of the lipid picture. You can read more about what the test measures on the LDL Cholesterol page.
Apolipoprotein B counts particles rather than cholesterol, so it can be high in someone whose LDL cholesterol looks perfectly acceptable. Each plaque-forming particle carries exactly one apoB molecule, so the result is effectively a headcount of the particles capable of entering an artery wall.
That distinction matters because particles vary in size and in how much cholesterol they carry. Someone with many small, cholesterol-poor particles can show a reassuring LDL cholesterol value while carrying a large particle burden. Studies suggest that LDL cholesterol, non-HDL cholesterol and apolipoprotein B frequently disagree within the same person, and that these discordances change how cardiovascular risk is estimated 6.
Other things shift apoB as well. Insulin resistance, high triglycerides, central weight gain, alcohol intake, pregnancy and recent illness can all move it, and like any lipid marker it varies somewhat between draws. A result sits best next to LDL cholesterol rather than instead of it, since the gap between the two is often the informative part. The Apolipoprotein B page explains what the measurement covers.
Lipoprotein(a) is a largely inherited particle that routine lipid panels do not measure, so a person can have textbook cholesterol numbers and still carry a raised Lp(a) they know nothing about. It behaves like an LDL particle with an extra protein attached, and that extra protein changes what it does.
Research suggests that the cardiovascular risk carried by lipoprotein(a) is largely independent of LDL cholesterol, meaning the two contribute separately rather than one standing in for the other 7. Evidence suggests that lipoprotein(a) sits at the crossroads of plaque formation and clot formation, which is why it draws attention beyond the usual cholesterol conversation 8.
Because the level is set mostly by genetics, it stays fairly stable across adult life and is often measured once rather than tracked. Diet and training move it very little. Inflammation, kidney disease and pregnancy can nudge the value, and unit confusion is a frequent source of misreading, since nmol/L and mg/dL are not interchangeable. A raised result does not mean an artery is blocked. It is one piece of inherited context that is worth discussing with a clinician, particularly where heart disease has appeared early in close relatives. See the Lipoprotein (a) page for what the test covers.
C-reactive protein measures inflammation anywhere in the body and cannot tell you where that inflammation is coming from. It is made by the liver in response to inflammatory signalling, and the high-sensitivity version of the assay detects the low concentrations that fall within what most people consider normal.
That non-specificity is the whole point to understand. A recent cold, a dental infection, an injury, a very hard training block, an autoimmune flare, excess body fat, smoking and pregnancy can all raise the value. A single high reading in someone who felt unwell last week usually says more about last week than about their arteries, which is why repeat testing once the person is well is a common next step.
What the marker offers is context. Clinicians commonly look at it alongside lipid results when they are building a picture of overall cardiovascular risk, because inflammation is part of how plaque forms and becomes unstable. What it cannot do is confirm plaque, grade a narrowing or point to a specific vessel. The C-Reactive Protein page covers the measurement in more detail.
A clean lipid panel does not rule out plaque, because blood tests describe risk while imaging and flow measurements describe the artery itself. Several things stay invisible to bloodwork.
Plaque that is already present is the biggest one. Risk markers estimate probability over years, and a person can carry calcified coronary plaque with unremarkable lipid numbers. Research suggests that coronary artery disease is often present and undetected, and that scans taken for other purposes could be reviewed opportunistically to find it 1.
Narrowing in the legs is a second gap. Peripheral arterial disease is identified through history, examination and blood flow measurement rather than bloodwork. Studies indicate that prediction models built from routinely available clinical information may help identify people more likely to have peripheral arterial disease, which supports but does not replace proper assessment 9. In people with diabetes, research suggests that the standard ankle measurement can read falsely high because calcified vessel walls resist compression, so additional assessment is regarded as necessary 3.
How disease presents is a third gap. Research suggests that coronary artery disease in women involves sex-specific differences in how it develops and how it shows up clinically, so a symptom pattern that does not fit the classic description still deserves assessment 2.
Finally, a large part of cardiovascular risk never appears in a tube of blood. Blood pressure, smoking history, sleep apnoea, sedentary time, visceral fat, family history and chronic stress all matter, and none of them are lipid values. Lab results also vary between draws, so one set of numbers is a snapshot rather than a verdict.
Some patterns need emergency care rather than an appointment. Call 911 or your local emergency number for chest pressure, tightness or pain that lasts more than a few minutes or goes away and comes back, pain spreading to the arm, jaw, neck, back or stomach, sudden breathlessness, a cold sweat with nausea or lightheadedness, or fainting.
Stroke signs need the same response. Sudden face drooping, weakness or numbness on one side, slurred or confused speech, sudden severe headache or sudden loss of vision all require emergency care immediately, not a wait-and-see approach.
A leg or foot that suddenly becomes cold, pale or blue, numb or severely painful also needs emergency assessment, because that pattern can reflect an abrupt loss of blood flow.
Book prompt, non-emergency care for new chest discomfort that appears reliably with exertion and settles with rest, for cramping in the calf, thigh or buttock that starts at a predictable walking distance, for foot or toe wounds that are slow to heal, or for foot pain that wakes you at night and eases when you hang the leg over the edge of the bed.
If a lab result comes back outside the standard range, that is a suboptimal value worth discussing with a clinician promptly, not something to ignore and not something to self-diagnose from. One number never establishes a condition, and treatment decisions belong to a licensed provider.
If you are having thoughts of self-harm, call or text 988 (US) or your local emergency number now.
All four markers come from a standard venous blood draw, and most laboratories run them together. The FitScript Essential panel measures LDL cholesterol, apolipoprotein B, lipoprotein(a) and C-reactive protein alongside the rest of a broad baseline, so the lipid picture can be read as a whole rather than one value at a time.
Atlas, FitScript's AI health advisor, explains what each result means in plain language, flags which values sit outside the standard range, and shows how they move between draws. Members have 150+ biomarkers tested per year, which makes trend over time more informative than any single snapshot. A licensed clinician reviews findings and decides on any next step, including whether further assessment or imaging is appropriate.
This article is educational and is not medical advice. Discuss your results and any treatment with a clinician or licensed provider who knows your full history.
Coronary artery disease often shows up as pressure, tightness or heaviness in the chest that appears with exertion and eases with rest. Breathlessness, jaw, neck, arm or back discomfort, nausea, cold sweat and unusual fatigue can occur, and some people notice no chest pain at all. New or lasting chest pain needs emergency care.
Peripheral artery disease most often causes cramping, aching or fatigue in the calf, thigh or buttock that starts after a predictable walking distance and settles within minutes of stopping. Cold feet, slow-healing sores, pale or shiny skin and leg hair loss can appear. A suddenly cold, pale, painful leg needs emergency care.
Yes. Plaque builds inside the artery wall and can grow for years without limiting blood flow enough to cause anything noticeable. Symptoms usually arrive late, which is why risk markers and family history matter before anything is felt. A clinician decides whether further assessment is appropriate.
No. Blood tests measure risk factors circulating in your blood, not the state of any particular vessel. Imaging and blood flow measurements are what show narrowing. Markers like LDL cholesterol, apolipoprotein B, lipoprotein(a) and C-reactive protein help a clinician judge how likely plaque is to be forming over time.
LDL cholesterol measures how much cholesterol your particles carry, while apolipoprotein B counts the particles themselves. Someone with many small, cholesterol-poor particles can have an acceptable LDL figure and a high particle count. The gap between the two numbers is often the useful part, and a clinician interprets it alongside your history.
A raised lipoprotein(a) means you carry more of an inherited particle that standard lipid panels do not measure. It does not mean an artery is blocked. Because the level is set largely by genetics, it is usually measured once rather than tracked, and it is worth discussing with a clinician alongside your family history.
Not on its own. C-reactive protein reflects inflammation anywhere in the body, so a recent infection, dental problem, injury or very hard training block can raise it. A single high reading is often temporary. Retesting once you are well, and reading the result alongside your lipid markers, gives a clearer picture.
That depends on your age, history and previous results, and a clinician decides the right interval for you. Lipoprotein(a) is usually measured once because it stays stable. LDL cholesterol, apolipoprotein B and C-reactive protein are commonly repeated so the trend, rather than a single snapshot, guides the conversation.